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Genomics Education for the Public:
Perspectives of Genomic Researchers and ELSI Advisors
Lynn G. Dressler,1 Sondra Smolek Jones,2 Janell M. Markey,3
Katherine W. Byerly,4 and Megan C. Roberts4
Aims: For more than two decades genomic education of the public has been a significant challenge. As genomic
information becomes integrated into daily life and routine clinical care, the need for public education is even more
critical. We conducted a pilot study to learn how genomic researchers and ethical, legal, and social implications
advisors who were affiliated with large-scale genomic variation studies have approached the issue of educating the
public about genomics. Methods/Results: Semi-structured telephone interviews were conducted with researchers
and advisors associated with the SNP/HAPMAP studies and the Cancer Genome Atlas Study. Respondents
described approach(es) associated with educating the public about their study. Interviews were audio-recorded,
transcribed, coded, and analyzed by team review. Although few respondents described formal educational efforts,
most provided recommendations for what should/could be done, emphasizing the need for an overarching entity(s)
to take responsibility to lead the effort to educate the public. Opposing views were described related to: who this
should be; the overall goal of the educational effort; and the educational approach. Four thematic areas emerged:
What is the rationale for educating the public about genomics?; Who is the audience?; Who should be responsible
for this effort?; and What should the content be? Policy issues associated with these themes included the need to
agree on philosophical framework(s) to guide the rationale, content, and target audiences for education programs;
coordinate previous/ongoing educational efforts; and develop a centralized knowledge base. Suggestions for next
steps are presented. Conclusion: A complex interplay of philosophical, professional, and cultural issues can create
impediments to genomic education of the public. Many challenges, however, can be addressed by agreement on a
guiding philosophical framework(s) and identification of a responsible entity(s) to provide leadership for devel-
oping/overseeing an appropriate infrastructure to support the coordination/integration/sharing and evaluation of
educational efforts, benefiting consumers and professionals.
Introduction
For more than two decades, educating the public aboutgenetics has been both a major concern and challenge
(Brownrigg, 1999; Chen, 2001; McInerney, 2002; Owens and
Breithaupt, 2002; Hsieh, 2004; Chen and Goodson, 2009; Du-
bochet, 2009; SACGHS, 2011; Bonham et al., 2012). When the
Human Genome Project (HGP) started in 1990, *5% of its
budget was set aside to support research related to the ethical,
legal and social implications (ELSI) of genomic research (Col-
lins and Mansoura, 2001). Four priority ELSI areas were iden-
tified, including the need for education and training. However,
after a few years, the education focus was discontinued along
with several other public education initiatives. Many factors,
including the complexity of the United States educational sys-
tem, contributed to the decision to end this priority area.
Since the HGP, almost every aspect of genomic research has
changed-scope, technology, applications, and societal impli-
cations. Most large-scale genomic studies have transitioned
from population-based to individual, often disease-based
studies collecting coded but linked individual genomic and
clinical information. Technological advances now provide
scientists the opportunity to sequence the genome at a rea-
sonable cost and there is a growing expectation that genomic
information will soon be incorporated into routine clinical
practice (Burke and Diekema, 2006; Dressler et al., 2012).
Genomic information related to health and disease is currently
being discussed in popular media; genomic tests are being
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directly marketed to consumers; (ACMG, 2008; Sterling,
2008; McBride, et al., 2010) and the translation of genomic
findings into clinical care is a major driver of biomedical re-
search (Dressler and Juengst, 2006; Green, et al., 2011). As
genomics has entered the public’s eye, there has been a re-
surgence of efforts to educate the public (American Society of
Human Genetics (ASHG), 2013; Chen, et al., 2008; Kaphingst
et al., 2009; Verhoeff, et al., 2009; Korf, 2011) about the
relationship between genomics, health, and disease.
Although numerous efforts are currently underway, educat-
ing the public about genomics continues to be a challenge
(Dubochet, 2009; Lea et al., 2011; SACGHS, 2011; Sorensen
and Brand, 2011; Bonham et al., 2012; Leshner, 2012). Many of
the same questions from early genome variation studies remain
unanswered, (Brownrigg, 1999; Chen, 2001; McInerney, 2002;
Hsieh, 2004; Bonham et al., 2012) including fundamental issues
related to how the public should be educated; who should be
responsible for this education effort; and what should be the
goals and objectives of public education programs.
We conducted a pilot study to learn how genomic re-
searchers and ELSI advisors, who were affiliated with past and
current large-scale genomic variation studies, have approached
this issue. This work is part of a larger study to understand how
a variety of ethical, legal, and social issues have been addressed
in large-scale genomic studies. This article focuses on one of
those issues, educating the public about genomics.
Methods
Overview
Two main projects were selected to represent early and cur-
rent large-scale genomic studies: the SNP/HAPMAP studies and
the Cancer Genome Atlas (TCGA) study, respectively. We re-
viewed the literature and publically available documents and
conducted a content analysis of the ESLI issues associated with
these studies. Five major issues emerged that continue to be
relevant today: (1) educating the public about genetics and ge-
nomics; (2) concern about group harm; (3) reciprocity and return
of research results; (4) collection and use of human specimens;
and (5) access to and sharing of genomic data and related clinical
and personal information. These five areas provided the frame-
work for interviews with genomic researchers and ELSI advisors
associated with the SNP/HAPMAP and TCGA studies to un-
derstand how these issues have been or can be addressed. The
results presented here focus on the respondents’ perspectives and
experiences related to educating the public about genomics.
Semi-structured interviews
Population. Using publically available information, we
invited 76 genomic researchers and ELSI advisors associated
with the SNP/HAPMAP and TCGA studies to participate in
semi-structured one-time interviews. Individuals who had
participated in one or more of the studies of interest, espe-
cially those who were involved in study development, design,
conduct, and ethics oversight, were invited to participate. We
contacted individuals by email and then followed up with
phone calls to confirm interest in participating and, if inter-
ested, to coordinate a time for the interview. Although all
interview responses were anonymized, at the request of
several individuals to further protect their privacy, responses
from researchers and ethics advisors were pooled. Because of
this, all data are represented as one group of respondents and
were not stratified into responses from ‘‘researchers’’ and
responses from ‘‘ethics advisors.’’
Approach and analysis. Informed by the literature review
and content analysis (see supplementary material), an inter-
view guide was developed, tested with a group of genomic
researchers and ethics advisors unaffiliated with the SNP/
HAPMAP or TCGA studies, and revised for subsequent one-
on-one semi-structured interviews. Phone interviews lasting 45
to 60 min were conducted by two interviewers (LD and SJ).
Both interviewers were trained for consistency, approach, and
content. The interview consisted of three main sections (see
supplementary data for details): (1) general impressions of
ELSI issues related to the respondent’s study(s); (2) specific
ELSI issues and how they were addressed (five areas, including
genomic education of the public); (3) common threads, lessons
learned, and remaining challenges. In section 2, for the specific
issue of education, each respondent was asked to describe the
policy, approach, or activities that were associated with edu-
cating the public about their study and/or genomics in general.
Respondents were asked to describe the effectiveness of these
(or other) programs to improve the public’s or community’s
understanding of genetics, genomics, and health, and how
these programs can be improved, including what is required to
do this. For analysis, any mention of ‘‘education’’ or ‘‘health
literacy’’ throughout the interview was coded.
All interviews were audio-recorded, transcribed, and as-
signed a study identification code. No personal identifiers were
collected and no master list was maintained that linked the
code to the respondent. Verbal consent was obtained from all
respondents. We followed established qualitative methods
criteria to assure the rigor and trustworthiness of data collec-
tion, coding, and analysis procedures (Strauss and Corbin,
1990; Patton, 2002; Charmaz, 2006). First, transcripts were
checked for accuracy, and the interview text was then analyzed
for content related to genomic education and health literacy.
After development of a coding schema by the study team, two
analysts ( J.M. and S.J.) coded the transcripts independently
and compared for agreement. Areas of disagreement were
resolved through discussion, and when necessary, by a third
coder (L.D.). The ATLAS.ti software program was used to aid
in indexing (i.e., attaching codes to interview text), searching,
and retrieving sections of data related to genomic education.
In-depth analysis of the coded data was conducted by team
review through a rigorous iterative process of analytic induc-
tion using a grounded theory approach (Denzin, 1989; Strauss
and Corbin, 1990; Charmaz, 2006). We also collected demo-
graphic information from each respondent, including age, sex,
education, primary field of expertise, years of experience,
study affiliation(s), and role(s) on the study (project planning/
study design, ELSI advisor, primary investigator).
This study was reviewed and approved by the University of
North Carolina Institutional Review Board (IRB).
Results
Demographics of respondents
Twenty-five individuals agreed to participate in the inter-
views, 16 males and 9 females. Our respondents were highly
educated (16 PhDs, 8 MDs, and 1 R.N.), and many had par-
ticipated in multiple large-scale genomic studies (HGP/
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HAPMAP/SNP/1000 genomes/TCGA). Primary fields of ex-
pertise included ethics/law/policy (7), genetics/genomics (10),
medicine (3) and other (1 each: theology, consumer, public
health, and informatics). One respondent did not report pri-
mary field of expertise. None of the respondents described
their profession as being related to education or communica-
tion.
General perspectives and experiences
with genomic education
Nearly every respondent discussed the need to educate the
public. Except for the HGP, however, few of our respondents
reported any formal public education programs associated
with their study. Instead, most responses focused on what
should be done rather than providing descriptions of what has
been or is currently being done. Overall, education ap-
proaches were described by some as being ‘‘more feasible’’
when they targeted a specific disease, such as cancer, or a
specific group, such as high school students. Others high-
lighted the difficulty in determining the ‘‘best’’ approach to
educating a diverse group of people, even if, for example, the
group is composed of all cancer patients.
Five thematic questions emerged from the analysis de-
scribing how our respondents were speaking about educating
the public: (1) What is the rationale or purpose for educating
the public about genomics? (2) Who is the intended audience
for education? (3) Who should be responsible to educate the
public? (4) What should these programs look like–what ap-
proaches should be used, what should the content be? and (5)
Why is educating the public so hard?
What is the rationale for educating the public
about genomics?
Our respondents described a variety of reasons why it is
important to educate the public about genomics, especially as
it relates to health (Table 1). Several respondents reported




‘‘I have seen a real interest [develop] in education about this [genomics] among people. A lot of
this stuff was new when we did it [in 1997]. People didn’t think about it much. Now a lot of
people think about it [genomics and health]. . It’s hard to repress it [genomic information].
So having people themselves saying ‘I know how it’s being used, and I want to address my




‘‘I think these kinds of studies (SNP, HAPMAP, TCGA) . in a major way demand that we
communicate what it is we’re looking for, and . to the extent that we find something that we
do a better job of explaining what those findings mean.’’ (P24)
‘‘Why shouldn’t the American public know that there are a zillion kinds of cancers, [that] there
are also different kinds of pieces of them . [DNA samples, tissue samples, urine sample] . as
opposed to lumping it all together and saying ‘We want a biospecimen.’ So I just see it as an
obligation to educate as well.’’ (P15)
Rapidly changing nature
of genomic research
‘‘We’re in a situation where the technologies and the information that we’re generating today
and even more tomorrow are not known to the general scientific community [nor] the general
public. Most of these things were invented after the people that are affected went to school.
It’s devilishly complicated in some cases. And so I think that we really do have to work on
public education at a level that we haven’t done in the past and that as far as I can tell nobody
is currently thinking about doing.’’ (P22)
Minimize harm ‘‘I think, in general, any effort to increase the public’s knowledge about genetics and genomics
is useful, particularly where we’re talking about difference, and our society is so based on
difference and not just talking about difference but valuing difference and ranking
difference.’’ (P24) ‘‘Making sure people understand what genetic variation means, and that
we don’t get misinterpretation and misunderstanding of these things. We already [have] a lot
of problems in this society with an over-estimate of the importance of genetics and with
genetic determinism . if people start thinking about complex behavior or mental processes in
the same way they think aboutTay-Sachs or Huntington’s disease that is a misunderstanding
[that] can be very dangerous.’’ [P5]
Reduce fear and
misunderstandings
‘‘. some people [are] just saying, ‘I don’t want to do it. You know I’m afraid of it [participate
in a research DNA databank].’’’ (P8).
‘‘. when people find out they’re at risk for say breast cancer, they sort of disappear from the
[health care] system because now they’re scared. . there’s dozens of social aspects which
you need to take into consideration. So that’s a big problem. (P13)
Trust and transparency
in science
‘‘. public support is critical to what we do, and the only way you get public support and trust is
to earn it.’’ (P14)
‘‘. you want people to understand where their money’s going and what you’re trying to do
with it.’’ (P12)
‘‘. there’s a disconnect between what the public is exposed to and [their] level of genetic
literacy and genetic knowledge . the disconnect has to do with understanding what is
actually possible; what a test or a piece of research can do for you or your community.’’ (P23)
aP, participant code.
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that it is timely to provide this education because both the
science and its ethical implications have ‘‘become real’’ and
have entered the public consciousness, especially with direct
to consumer marketing of tests and popular media coverage.
Some respondents described that education is needed because
of the inevitability of genomic medicine being part of routine
health care. Many described how the rapid pace of research,
especially new knowledge generation and its implication for
gene–disease relationships, is not well understood by most
scientists, much less the ‘‘general public.’’ A sentiment de-
scribed by several respondents was that education was a re-
sponsibility or obligation that should be taken seriously. For
some physician respondents, education was a natural exten-
sion of ‘‘what we always do in clinical care’’ (i.e., educating
about genomics is similar to educating the patient about the
procedure they will be having). Other respondents described
how education was more about good communication and
that scientists ‘‘need to do a better job of explaining what
[genomic] findings mean.’’
Minimizing harm to groups or individuals was another ra-
tionale described for educating the public. This was based on the
belief that through education the public would gain an under-
standing of human diversity and genetic variations, and conse-
quently the tendency to ‘‘rank differences’’ as good and bad
should shift to understanding differences as ‘‘something more
neutral.’’ Many respondents described that, with education, the
public would be in a position to ‘‘better balance’’ the anticipated
benefits, limitations, and potential harms of genomic informa-
tion, thereby minimizing current fears or misperceptions about
genomics and also lead to empowering individuals to be more
informed and involved in their health care decisions.
For some respondents, education was also considered a
critical component of the research enterprise, and that
‘‘public support is critical to what we [researchers] do.’’
Through ‘‘education and transparent communication,’’ in-
cluding clearly explaining ‘‘what is actually possible, without
hype,’’ the public can develop trust and support for genomic
science and increase participation in research studies.
Who is the audience?
Our respondents discussed a wide spectrum of public au-
diences for whom genomic education should be provided
(Table 2). Five groups of ‘‘publics’’ were most commonly
identified: (1) students, especially those in high school; (2)
potential research subjects being recruited for genomic re-
search; (3) patients who were under the care of a physician;
and (4) the ‘‘general’’ public (not otherwise specified). In
discussing the HGP, one respondent indicated that the public
was considered by NHGRI to include ‘‘broad audiences
[from] PBS series to high schools to town meetings for the
public.’’ High school students were considered one of the
important audiences, ‘‘starting about 10th grade.’’ Some
described a ripple effect ‘‘because they [the students] go
home and educate their parents.’’ Respondents also recog-
nized that high school education programs would require
having ‘‘instructors who were competent to deal with these
[genetic] complexities.’’
Who should be responsible for education?
Although we observed strong support for educating the
public, positions varied widely regarding who should be re-
sponsible for this effort (Table 2). The sentiment that edu-
cation was ‘‘someone else’s responsibility’’ was commonly
articulated: ‘‘Eventually [we] decided maybe public educa-
tion was somebody else’s job [not the NHGRI or HGP].’’ The
different perspectives on whose job it should be included
teachers, health care providers, researchers, government,
NIH and professional educators. Responsible entities to lead
and fund the educational effort were similarly diverse (e.g.,
secondary school system, the scientific community, the
medical community, the specific genome variation study, the
NIH, NSF, and the government). Some positions were also
contradictory, where the same entity (scientific community,
NIH, government) was held responsible by some respon-
dents, but not by others. However, respondents did agree that
someone or some entity needs to be in charge and responsible
for educating the public.
What should education programs look like:
approach and content?
Except for the early phase of the HGP, few described
previous or existing formal education programs associated
with their study. Instead, most respondents provided sug-
gestions for the types of educational approaches that should
be considered and the content of a public education program.
Suggestions varied widely and addressed both general edu-
cational approaches and specific content areas (Table 3).
Several respondents underscored the need for educational
approaches to be culturally sensitive, including respecting
personal identity when scientific findings are in conflict with
origin stories.













Patients Health care providers
Public Health Educators
Potential research subjects Researchers; Funders
General public (not
otherwise specified)
















New or expectant parents NS
Disease-oriented societies NS
NS, not specified.
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For both high school students and the general public, most
respondents highlighted the need for innovative educational
approaches including opportunities associated with the
‘‘digital age’’ and ‘‘social media.’’ Several described the
need for a concerted effort to develop public internet infor-
mation sites. One respondent suggested a ‘‘continuing patient
education site,’’ analogous to continuing education for cli-
nicians. Another suggested the development of a ‘‘national
online clearinghouse of [genomic] information for the pub-
lic’’; a site that would be vetted and updated by experts and
communicated in plain language. Respondents also under-
scored the need to have end-user (i.e., the public) feedback
regarding what and how they want to learn. Relevant to this
theme was the importance of community engagement, in-
cluding employing different approaches to accomplish this,
‘‘from Community-Based-Participatory Research (CBPR)’’
to community lectures. Another common theme focused on
‘‘avoiding hype,’’ utilizing an ‘‘unbiased, transparent,’’ and
honest approach about the opportunities and limitations of
genomics research.
Although the suggested content of these programs was
variable and sometimes conflicted from one respondent to
the next (Table 3), some common themes emerged. One
theme was a philosophy that education should provide a
common sense understanding of genomics; with a ‘‘solid
curriculum that is broadly disseminatable.’’ Respondents
did not expound on what this means, nor how to do it. An-
other theme focused on the need to define and explain terms
consistently (e.g., genetic variation; genetic research),
whether during an informed consent process or in the de-
velopment of a public education program. In addition, many
respondents described their concern about the harm of
‘‘genetic determinism’’ and how education should address
(and minimize) this concern.
Often respondents recommended that education should
include the ethical and social implications of genomic re-
search. The discussion of ELSI issues was also supported in
the context of the informed consent process, although some
respondents cautioned against making this part too detailed.
Although ELSI was considered important, others wanted
more emphasis placed on ‘‘understanding the scientific pro-
cess,’’ citing how the informed consent process is an op-
portunity for educating potential research subjects about how
science is conducted, including the need to validate findings.
A few respondents emphasized how the informed consent
process should make clear certain details and nomenclature,
such as what it means to ‘‘take a DNA sample’’ and ‘‘what it
might mean in terms of creating cell lines.’’
Although some respondents suggested that education of
the public be ‘‘study-specific’’ (e.g., related to SNP/HAP-
MAP or TCGA), others suggested that the public health
benefits are more important to focus on, ‘‘the benefits to the
community will accrue from improvements in public health
not from understanding the purpose of the project.’’
Why is this so hard?
Our respondents described many challenging, often inter-
woven issues associated with educating the public. Five main
themes emerged from their discussion (Table 4).
1. Need for supportive infrastructure, approach, and
leadership: In addition to the need for financial resources, a
main issue described by many respondents was that there
was no clear entity responsible for taking ownership of this
issue. Respondents also recognized the challenges of
working with a public education system, which has rigid
curricular requirements. One respondent suggested that an
issue plaguing the development of education programs is the
need to be absolutely correct, ‘‘we are too serious about
making a mistake.’’ Other respondents spoke about the need
to integrate the ‘‘silos of research,’’ because the ‘‘frag-
mentation [of the research process]’’ delays the translation
of information to clinical care. One respondent emphasized
the need for a coordinated effort from NIH to provide
consistency across all NIH institutions in nomenclature and
language used to explain genome studies, especially in in-
formed consent documents.
2. Diversity of individuals and groups: One of the most
complex challenges, mentioned earlier, is the large variation
among individuals and groups related to their education,
literacy, language, and views of how genetics influences
health.
3. Political, Economic, and Philosophical Factors: Re-
spondents also raised the concern that ‘‘special interest’’
groups, such as direct-to-consumer marketing firms, may be
providing biased genomic education to a segment of the
population. One respondent suggested the need for a culture
that considers participating in science as ‘‘the right thing to
do [as a society].’’
Table 3. Content and Approach
of a Public Education Program
Approach
 Culturally sensitive and innovative approaches
 Genomics in context, situational
 Avoid hype, be neutral about importance
 Be honest about where taxpayer money is going
 Ask public what they want to know and understand
Content
 Common sense understanding of genomics
 Understand how genomics improves health, not what
alleles do
 General genomic education, not study specific
 Study-specific education (e.g., related to TCGA,
HAPMAP, etc)
 Concepts and definitions (genetic determinism, genetic
variation, DNA, genetics, risks, benefits)
 Clear communication about the meaning of study results
 Importance and limitations of science; scientific
research process
 Implications of genomics for individuals, family, and
society (ethical, legal, social)
 Understand sharing information among investigators,
clinicians, patients, research subjects
 Economic and political aspects of genome science
(DTC, pharma, healthcare)
 Details about DNA banking and data banking
 Informed consent process/forms with consistent
language, definitions, descriptions relevant to genomics
research and testing
 Risk and benefit of participation in clinical trial and
nonclinical studies
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4. Complexity of genome science: Aside from the rapid
pace and volumes of information generated from genomic
studies, some of our respondents described the challenge of
disseminating evolving findings and that key stakeholders
and experts either differ or are not sure what is important for
the public to know: ‘‘Genetics is pretty complicated even for
those of us who do nothing but that.[I’m] not sure what is
important for the public to know.’’
5. Conflicting views on fundamental issues: Adding to
this complexity are conflicting views on some fundamental
questions (Table 5) This included who should be responsible
to lead this effort, for example, whether educating the public
should be the role of government, NIH, or researchers; what
the the goals of a public education program should be,
whether this should be ‘‘to shape [a] new world view’’ about
the role of genetics in human behavior [and] in human ac-
tivity’’ or to improve communication between researchers,
clinicians, and research subjects. Since the goal often shapes
the content, it was not surprising that different conceptual
views also existed for what should be included in a public
educational program (e.g., scientific details specific to the
project or a general concept of the science).
Discussion
Although the data presented reflect the perspectives and
experiences of our respondents and may not be generalizable
to all genomic researchers and ELSI advisors, they offer
important insights.
First is the need for an entity to take ownership and re-
sponsibility for leading the effort to educate the public; who
that should be, however, represents one of the most con-
troversial and challenging issues described by our respon-
dents. Many of our respondents did not feel that scientists or
the research community could or should do this. Instead,
similar to the literature, respondents identified health care
providers (ACMG, 2008; Christianson et al., 2010; Sorensen
and Brand, 2011; Syurina et al., 2011) and public school
teachers (Wefer and Sheppard, 2008; Verhoeff, et al., 2009;
Dougherty et al., 2011) as the main vehicles for genomics
education for the public. Other respondents echoed sugges-
tions by SACGHS (2011) and others (Byk, 1998) that the
government (e.g., Department of Health and Human Services,
Department of Education) should take a leading role in this
effort. Indeed, important steps are currently being taken at the







There is no clear entity to own this effort (P18)
Need professional educators (P12)





Variable informed consent process
Rigid curricular requirements (P1)
Need to integrate research silos (P15)
Fragmentation of research process
Need for uniform consent process
Diversity of individuals/groups
Variable social, economic, cultural factors
SES/Education/literacy
Views of health care and genetics
Identity issues
Many barriers/complications to public education, including variable
literacy, education, language, and views of health care; (P13, P23)
Personal identity/creation stories in conflict with science; need a more




Individuals and groups have different information-seeking behaviors,
needs, and sources of information (generational, situational) (P17, P19)
Political and economic factors
Commercial industry
Special interest groups
Public trust and support of science
Few incentives to educate public
Prevent misinformation or desensitization to risks from DTC, pharma,
commercial organizations with incentive to communicate biased
information (P7);
Lack of incentive for noncommercial entity to educate public (P11, P22)




Concerns about genetic determinism
The science is very complicated and it advances, changes, or evolves
every 18 months, how to disseminate information? (P22, P18)
Key stakeholders and experts differ on what’s important to know (P20)
SES, socioeconomic status.
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federal level (NSF, 2012; CDC, 2013; STEM, 2013) and
throughout the National Institutes of Health (NCI, 2013;
NHGRI, 2013; NIGMS, 2013). Professional groups (ACMG,
2011; ASHG, 2013) also play a significant role in the devel-
opment of genomic education programs for the public. Al-
though these efforts collectively represent enormous gains,
they have largely been independent activities.
Second, is the need for these leaders to be expert not only
in content knowledge of genomics, but also in different ed-
ucational approaches for individuals and populations of di-
verse demographics (e.g., education, literacy, cultural, social,
and religious) and different attitudes, beliefs, and behaviors
about their health. These concerns are similar to those ex-
pressed in the NHGRI strategic plan white papers (NHGRI,
2011) and SACGHS (2011). Many federal (e.g., NIH, CDC,
NSF), national consumer groups (Genetic Alliance, 2013),
and professional groups [ASHG, ACMG, NCHPEG (2007)]
offer a spectrum of traditional and innovative approaches,
expert-developed content, and multiple resources for edu-
cating K-12 and college students, trainees, and health care
professionals. Similar to some of our respondents, SACGHS
emphasizes the need to develop strategies that improve ge-
netic literacy among diverse populations, with the expecta-
tion that education in under-represented and low-literacy
populations could prevent further increases in health dis-
parities, highlighting the importance of community partici-
pation (SACHGS, 2011) (Christianson et al., 2010).
Consolidating and sharing these different approaches would
help inform best practices for more widespread and efficient
public benefit.
Table 5. Differing Perspectives Related to Genomic Education for the Public
Issue Perspective Quote
Who is responsible Pro-NIH/NSF: ‘‘NIH and NSF ought to pay .’’ (P20)
‘‘. you need to have an educational limb to the NIH.’’(P7)
‘‘consistency across these [NIH]institutes . (P7) about how we’re
educating our public whether it’s the cancer public or the NIDA
public. ’’(P15)
Pro-individual project ‘‘. to the extent that it’s possible, these projects should have (and
maybe not each one have its own) public education effort. . (P24)
Anti-NIH/Individual
project
‘‘I don’t think we’re doing quite enough, but [specific NIH project]
should not be the educational vehicle to educate the public about the
value and the dangers of genomics. There needs to be another
organization . maybe a spinoff child.’’ (P7)
Pro-scientific
community
‘‘Probably the scientific community is going to have to do this [public
education] . they’re the people that are on the front end of
the . ‘generation’ business.’’ (P22)
NIH [needs] to be saying that the scientific community . needs to be
engaged in this, and this means you.’’(P14)
Anti-scientific
community
‘‘you can’t expect them [scientists] to be a public communications firm.









‘‘Probably more important . to include opportunities for people to
understand about the research process, what it involves, what different
kinds of research do, and what’s the path from any particular type of
research activity to potential benefit . that is far more central than
whether people understand what an allele is.’’ (P20)
‘‘It [the project]is for the community, and the benefits to the community
will accrue from improvements in public health not from [an]
understanding of the purpose of the project.’’ (P9)
Specific understanding
of science and study
‘‘Making sure people understand what genetic variation means, and that
we don’t get misinterpretation and misunderstanding of these
things . if people start thinking about complex behavior or mental
processes in the same way they think about Tay-Sachs or
Huntington’s disease that is a misunderstanding, but misunderstand-







‘‘I think these kinds of studies (SNP, HAPMAP, TCGA) . in a major
way demand that we communicate what it is we’re looking for,
and . to the extent that we find something that we do a better job of
explaining what those findings mean.’’ (P24)
Shape a new world
view
‘‘It has to be done in K-12 education . where people’s thoughts and
attitudes are formed because in some ways this is an . educational
process about the role of genetics in human behavior, in human
activity. That’s not just a scientific issue. It’s really a kind of a world
view, and I think we need to shape that world view. (P5)’’
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Third, conflicting perspectives among our respondents on
fundamental issues of education further illustrate how
challenging it is to conceptualize an education program.
Although overall support for public education exists, re-
spondents were at odds regarding the purpose of such a
program; who the public consisted of; who was responsible
for this education; and what the content should be. We in-
terpret this observation as being another example of why
educating the public is so hard. Without agreement on fun-
damental issues of purpose and goals, development and
implementation of public education programs will likely be
inefficient and ineffective.
Finally, the complex interplay of these issues creates a
major barrier to genomic education. Even after fundamental
issues are agreed upon, it is still necessary to navigate through
a complicated web of political, cultural, and structural pres-
sures, within and across medical, scientific, and educational
disciplines. Considering all these issues, it is not surprising
that 13 years after the HGP was completed, the issue of public
education is still a major concern.
Next steps
The need for genomic education will only grow as ge-
nomic information becomes more integrated into daily life
and routine clinical care. The original intent of this pilot was
to identify and consolidate successful approaches and les-
sons learned related to educating the public. Instead, our
respondents helped to identify continuing challenges and
key educational policy issues that need to be addressed.
With the numerous educational initiatives currently ongo-
ing or planned, there is great opportunity to revisit this
original intent to inform best practices. Informed by the
comments from our respondents, the authors suggest that
the following next steps be considered.
Consolidate experiences. An overarching group, such as
the Institute of Medicine, the NIH, or DHHS, should cham-
pion the process of identifying, tracking, and coordinating
these initiatives and consolidating the growing body of ap-
proaches, methods, and experiences to identify lessons
learned, best practices, gaps, and challenges remaining.
Develop programmatic goals derived from a shared phi-
losophy. Roundtable discussions, think tanks, and/or sym-
posia are needed to bring together key inter-disciplinary
stakeholders in academia, government, for-profit, and not-
for-profit organizations, not only to share findings, but also to
develop consensus on the goals of a consolidated program.
Best practices will be different for a program whose goal is to
reaffirm the existing American philosophy of public educa-
tion (i.e., to create an informed citizenry capable of govern-
ing itself–including the science it endorses and supports)
compared to one that supports another framework, such as
advancing public health by getting more Americans involved
in genomic research and increasing uptake of genomic
medicine.
Identify knowledge gaps and need for additional re-
search. The process of reviewing what is being done and
what has already been learned offers the opportunity to
identify what additional research should be done and develop
consensus around prioritizing which research questions
should be addressed. For example, should K12 education
competencies set the standard for education of the general
public? Should the general public be more involved in what
and when they want to learn about genomics? And how does
what the public wants to know compare with what health
educators, teachers, and health providers feel the public
should know?
Centralized knowledge base. There is a need to develop
and maintain a database to collect and consolidate the dif-
ferent initiatives, approaches, methods, instruments, evalua-
tions, and best practices for public education, a ‘‘dbGAP’’ for
education. There is also a need to develop a coordinated,
scientifically vetted, and user-friendly public database of
educational modules, Websites, interactive learning pro-
grams, and/or downloadable smart phone applications that
are available to the general public and for health care pro-
viders, teachers, and others to refer their patients, students, or
constituents. This evidence base should inform educational
programs aimed to increase genomics knowledge in a feed-
back loop of continual learning and improvement.
Incorporate evaluation as a component of any public ed-
ucation program. There is a need to incorporate an evalu-
ation component for each public education program, relevant
to the program’s goals and objectives. This will require the
development of a shared set of metrics to assess a program’s
strengths, weaknesses, and effectiveness. A consistent set of
benchmarks for program evaluation would allow collection
and comparison of similar data across studies (e.g., a com-
parative effectiveness approach to efficiently inform best
practices). For example, metrics could help address when and
how to assess whether a program is ‘‘working’’-whether it is
meeting its goals; whether program recipients are satisfied;
and what approaches work best for measuring changes in an
individual’s understanding of genomics information and/or
the impact on their health-care decisions. Incentives from
funding organizations could promote the sharing of this in-
formation.
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